UPDATE : Monday, August 10, 2020
상단여백
Novartis’ asthma drug gets insurance benefit by Shim Hyun-tai 2020-07-01 20:05
Takeda Korea completes takeover of Shire Korea by Lee Han-soo 2020-07-01 17:39
Hanmi to export dyslipidemia drug to Mexico via MSD by Shim Hyun-tai 2020-07-01 14:19
Hanmi's short bowel syndrome treatment wins rare pediatric disease status by Lee Han-soo 2020-06-30 17:38
Hugel submits NDA for BTX product in Europe by Lee Han-soo 2020-06-30 15:36
라인
KPBMA to expand local drugmakers’ exchanges with Europe by Kim Chan hyuk 2020-06-30 14:09
Bukwang to change clinical design for Covid-19 drug candidate by Kim Chan-hyuk 2020-06-30 13:18
Samsung Bioepis’ drug to join bevacizumab biosimilar competition in Europe by Kim Chan hyuk 2020-06-29 16:08
Vivozon to start P3b trial of nonnarcotic analgesics in US by Lee Han-soo 2020-06-26 17:13
Helixmith pushes ahead with P3-2 trial for neuropathic pain treatment by Lee Han-soo 2020-06-26 16:38
라인
Celltrion tops pharmaceutical brand reputation in June by Park Gi-taek 2020-06-26 15:23
10 more Korean drugmakers nestle in Boston to enter US market by Kim chan-hyuk 2020-06-26 14:12
Alteogen signs $3.8-billion tech transfer deal with a global pharma by Shim Hyun-tai 2020-06-25 16:19
‘Use NEWS score system to detect high-risk Covid-19 patients early’ by Song Soo-youn 2020-06-25 15:07
Hanmi, Novartis in patent dispute over diabetes drug by Kim Yun-mi 2020-06-25 13:59
라인
Hanmi Science Presents 6 Great Visions for Post COVID-19 by Lee Han-soo 2020-06-24 18:02
GSK sure about Dovato’s changing HIV treatment paradigm by Lee Han-soo 2020-06-24 12:11
Hanmi to sell prostatism drug in Japan by Shim Hyun-tai 2020-06-23 18:17
[News Focus] Pfizer Korea's restructuring enters into last-minute tug-of-war with union by Lee Han-soo 2020-06-23 16:51
Labor-management dispute runs deep at MSD Korea by Kim Yun-mi 2020-06-23 12:06
여백
여백
여백
Back to Top